NewtekOne, Inc. - Common Stock (NEWT)

Passive income stocks help you build rising income for retirement and/or financial freedom. Passive income stocks are meant to be purchased once and never sold.

NEWT stock results show that NewtekOne beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

NEWT stock results show that NewtekOne beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

The company's higher profit margins allow NEWT to have among the highest-yielding corporate business accounts and offer the public the highest-yielding CDs in the land. 

NEWT stock results show that NewtekOne missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.

Navigate the banking shift, with these three bank stocks likely to erode shareholder value further amidst an uncertain environment.

Amidst a shaky financial landscape, these are the three bank stocks to avoid in January, reflecting market volatility.

Understand the risks of underperforming bank stocks in amidst the uncertainty in the market at this time offering little upside

Although not every financial institution is destined for the dumpsters, these worst bank stocks should probably be avoided.

Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire 3 programs related to the orphan hematology disorders.

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.